Brief: Zevra Therapeutics Presents New Data On The Long-Term Safety And Efficacy Of Arimoclomol
15/04/2024 23:00
April 15 (Reuters) - Zevra Therapeutics Inc ZVRA.O :
* ZEVRA THERAPEUTICS PRESENTS NEW DATA ON THE LONG-TERM
SAFETY AND
EFFICACY OF ARIMOCLOMOL AS A TREATMENT FOR NIEMANN-PICK DISEASE
TYPE C AT THE SIMD 45TH ANNUAL MEETING
Source text for Eikon: ID:nGNX1gYhjH
Further company coverage: ZVRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor